František Sedlák

412 total citations
19 papers, 283 citations indexed

About

František Sedlák is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, František Sedlák has authored 19 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Hematology. Recurrent topics in František Sedlák's work include Peptidase Inhibition and Analysis (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Chemical Synthesis and Analysis (3 papers). František Sedlák is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Chemical Synthesis and Analysis (3 papers). František Sedlák collaborates with scholars based in Czechia, Germany and Hungary. František Sedlák's co-authors include Petr Cígler, Pavel Šácha, Jan Konvalinka, Jan Štursa, Klára Grantz Šašková, Martin Hrubý, Miroslav Hájek, Ivan Řehoř, Václav Navrátil and Jan Tykvart and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Advanced Functional Materials.

In The Last Decade

František Sedlák

15 papers receiving 281 citations

Peers

František Sedlák

RNMI

ONCOL

Raghavendra Vasudeva Murthy India

Dongmyung Oh United States

Stephanie A. Fraser United States

Jee-Hyun Cho South Korea

Gayle Buller United States

Edward A. Esposito United States

Barbara K. Szpikowska United States

George Ueda United States

Dawn R. Christianson United States

Raghavendra Vasudeva Murthy India

František Sedlák

215 ×1.6

69 ×0.9

54 ×0.9

26 ×0.6

RNMI

67 ×1.6

ONCOL

Citations per year, relative to František Sedlák František Sedlák (= 1×) peers Raghavendra Vasudeva Murthy

Countries citing papers authored by František Sedlák

Since Specialization

Citations

This map shows the geographic impact of František Sedlák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by František Sedlák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites František Sedlák more than expected).

Fields of papers citing papers by František Sedlák

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by František Sedlák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by František Sedlák. The network helps show where František Sedlák may publish in the future.

Co-authorship network of co-authors of František Sedlák

This figure shows the co-authorship network connecting the top 25 collaborators of František Sedlák. A scholar is included among the top collaborators of František Sedlák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with František Sedlák. František Sedlák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Minařík, Jiří, Luděk Pour, Tomáš Jelı́nek, et al.. (2025). Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group. BMC Cancer. 25(1). 651–651.

Sedlák, František, Volodymyr Lobaz, Eva Tihlaříková, et al.. (2025). Solid Lipid Nanoparticles Coated with Glucosylated poly(2-oxazoline)s: A Supramolecular Toolbox Approach. Biomacromolecules. 26(2). 861–882. 2 indexed citations

Sedlák, František, et al.. (2024). Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition. ACS Chemical Neuroscience. 15(7). 1342–1355. 5 indexed citations

Venz, Simone, František Sedlák, Kallayanee Chawengsaksophak, et al.. (2024). DDI2 protease controls embryonic development and inflammation via TCF11/NRF1. iScience. 27(10). 110893–110893. 1 indexed citations

Radocha, Jakub, Jiří Minařík, Jan Štraub, et al.. (2024). A Multicenter Phase 2 Study Evaluating the Optimized Schedule of Belantamab Mafodotin 1.9 Mg/Kg Q8W Plus Bortezomib and Dexamethasone in Relapsed Refractory Multiple Myeloma. Blood. 144(Supplement 1). 1999–1999.

Kostka, Libor, et al.. (2024). Iridium‐based Polymeric Multifunctional Imaging Tools for Biochemistry. ChemPlusChem. 89(5). e202300647–e202300647.

Štork, Martin, Ivan Špıčka, Jakub Radocha, et al.. (2023). Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis. Annals of Hematology. 102(6). 1501–1511. 6 indexed citations

Lobaz, Volodymyr, František Sedlák, Ivana Šeděnková, et al.. (2023). Tuning polymer–blood and polymer–cytoplasm membrane interactions by manipulating the architecture of poly(2-oxazoline) triblock copolymers. Colloids and Surfaces B Biointerfaces. 231. 113564–113564. 3 indexed citations

Vaněk, Václav, František Sedlák, Jan Procházka, et al.. (2021). Lipid Nanoparticles for Broad‐Spectrum Nucleic Acid Delivery. Advanced Functional Materials. 31(47). 19 indexed citations

10.

Sedlák, František, et al.. (2020). Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma. Cancers. 12(5). 1065–1065. 29 indexed citations

11.

Neburková, Jitka, František Sedlák, Libor Kostka, et al.. (2018). Inhibitor–GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles. Molecular Pharmaceutics. 15(8). 2932–2945. 22 indexed citations

12.

Sedlák, František, Petr Kašpárek, Marek Malý, et al.. (2018). A novel PSMA/GCPII‐deficient mouse model shows enlarged seminal vesicles upon aging. The Prostate. 79(2). 126–139. 2 indexed citations

13.

Navrátil, Václav, Jan Tykvart, František Sedlák, et al.. (2017). Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII. FEBS Open Bio. 7(9). 1362–1378. 19 indexed citations

14.

Svoboda, Michal, Václav Veverka, Jean‐François Trempe, et al.. (2016). Human DNA-Damage-Inducible 2 Protein Is Structurally and Functionally Distinct from Its Yeast Ortholog. Scientific Reports. 6(1). 44 indexed citations

15.

Šácha, Pavel, Jiří Schimer, Jan Tykvart, et al.. (2016). iBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties. Angewandte Chemie International Edition. 55(7). 2356–2360. 29 indexed citations

16.

Tykvart, Jan, Václav Navrátil, František Sedlák, et al.. (2014). Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA). The Prostate. 74(16). 1674–1690. 30 indexed citations

17.

Hájek, Miroslav, Ivan Řehoř, František Sedlák, et al.. (2014). Designing the nanobiointerface of fluorescent nanodiamonds: highly selective targeting of glioma cancer cells. Nanoscale. 7(2). 415–420. 69 indexed citations

18.

Sedlák, František, et al.. (2013). Glutamate carboxypeptidase II does not process amyloid‐β peptide. The FASEB Journal. 27(7). 2626–2632. 3 indexed citations

19.

Sedlák, František, et al.. (2013). Hudební psychologie pro učitele.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact